CA2909855C - Reduced toxicity in alcoholic beverages - Google Patents

Reduced toxicity in alcoholic beverages Download PDF

Info

Publication number
CA2909855C
CA2909855C CA2909855A CA2909855A CA2909855C CA 2909855 C CA2909855 C CA 2909855C CA 2909855 A CA2909855 A CA 2909855A CA 2909855 A CA2909855 A CA 2909855A CA 2909855 C CA2909855 C CA 2909855C
Authority
CA
Canada
Prior art keywords
hepato
alcoholic beverage
glycyrrhizin
mass concentration
concentration range
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2909855A
Other languages
English (en)
French (fr)
Other versions
CA2909855A1 (en
Inventor
Harsha CHIGURUPATI
Manish Radheshyam Biyani
Biswajit AUDDY
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2909855A1 publication Critical patent/CA2909855A1/en
Application granted granted Critical
Publication of CA2909855C publication Critical patent/CA2909855C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12G—WINE; PREPARATION THEREOF; ALCOHOLIC BEVERAGES; PREPARATION OF ALCOHOLIC BEVERAGES NOT PROVIDED FOR IN SUBCLASSES C12C OR C12H
    • C12G3/00—Preparation of other alcoholic beverages
    • C12G3/04—Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs
    • C12G3/05—Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs with health-improving ingredients, e.g. flavonoids, flavones, polyphenols or polysaccharides
    • C12G3/055—Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs with health-improving ingredients, e.g. flavonoids, flavones, polyphenols or polysaccharides extracted from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12G—WINE; PREPARATION THEREOF; ALCOHOLIC BEVERAGES; PREPARATION OF ALCOHOLIC BEVERAGES NOT PROVIDED FOR IN SUBCLASSES C12C OR C12H
    • C12G3/00—Preparation of other alcoholic beverages
    • C12G3/04—Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs
    • C12G3/06—Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs with flavouring ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Botany (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Distillation Of Fermentation Liquor, Processing Of Alcohols, Vinegar And Beer (AREA)
  • Alcoholic Beverages (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA2909855A 2013-04-29 2014-04-28 Reduced toxicity in alcoholic beverages Active CA2909855C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1894/CHE/2013 2013-04-29
PCT/IB2014/061051 WO2014177989A2 (en) 2013-04-29 2014-04-28 Reduced toxicity in alcoholic beverages
IN1894CH2013 IN2013CH01894A (https=) 2013-04-29 2014-04-28

Publications (2)

Publication Number Publication Date
CA2909855A1 CA2909855A1 (en) 2014-11-06
CA2909855C true CA2909855C (en) 2016-08-30

Family

ID=50981589

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2909855A Active CA2909855C (en) 2013-04-29 2014-04-28 Reduced toxicity in alcoholic beverages

Country Status (12)

Country Link
US (2) US9149491B2 (https=)
EP (1) EP2992078B1 (https=)
JP (1) JP6194412B2 (https=)
CN (1) CN105143428B (https=)
AU (1) AU2014261082B2 (https=)
BR (1) BR112015026884A2 (https=)
CA (1) CA2909855C (https=)
EA (1) EA030485B1 (https=)
ES (1) ES2743075T3 (https=)
IN (1) IN2013CH01894A (https=)
MX (1) MX2015014956A (https=)
WO (1) WO2014177989A2 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2017016479A (es) * 2015-06-19 2018-08-15 Chigurupati Harsha Composicion de bebidas sinergicas.
EA201890810A1 (ru) * 2015-09-24 2018-11-30 Синью Фарма Инк. Соединения, эффективные для лечения гепатотоксичности и стеатоза печени, и их применение
WO2017084234A1 (zh) * 2015-11-19 2017-05-26 欣耀生医股份有限公司 预防或治疗脂肪肝的药物组合物
WO2017216813A1 (en) * 2016-06-18 2017-12-21 Chigurupati Harsha Composition to reduce dna and hepatic damage and to enhance repair thereof
WO2018061020A1 (en) * 2016-09-30 2018-04-05 Chigurupati Harsha A composition for dna protection
CN108753551A (zh) * 2018-07-05 2018-11-06 深圳市鑫木森实业发展有限公司 一种具有补肾养肝功效的sod白酒制备方法
WO2021050263A1 (en) * 2019-09-12 2021-03-18 Coors Brewing Company METHOD AND SYSTEM OF BEER SHELF LIFE EXTENSION BY pH NEUTRALIZATION
JP2023549244A (ja) 2020-11-14 2023-11-22 マーク アンソニー インターナショナル エスアールエル 発酵飲料の殺菌方法

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1720329A (en) 1926-09-25 1929-07-09 Us Process Corp Manufacture of fermented beverages of reduced alcohol content
US3107605A (en) * 1960-09-23 1963-10-22 Colonial Sugar Refining Co Extracting sucrose from sugar cane
US3282706A (en) 1964-11-23 1966-11-01 Macandrews & Forbes Company Sucrose-ammoniated glycyrrhizin sweetening agent
US4393200A (en) 1980-01-09 1983-07-12 Maruzen Kasei Kabushiki Kaisha 18 α-Glycyrrhizinic acid and salt thereof
JPS58870A (ja) 1981-06-20 1983-01-06 Hayashibara Biochem Lab Inc 飲食物及びその製造方法
EP0502554A3 (en) 1986-05-15 1993-03-10 Emory University Composition comprising an oxygen radical scavenger and a surfaceactive copolymer
WO1987007835A1 (fr) 1986-06-21 1987-12-30 Dainippon Ink And Chemicals, Inc. Medicament pour le traitement et la prophylaxie de maladies du rein et du foie
WO1989004165A1 (en) 1987-10-19 1989-05-18 Haklitch Joseph A Detoxifying food supplement
US4868207A (en) 1988-07-28 1989-09-19 Taisho Pharmaceutical Co., Ltd. Bis (methylenedioxy) biphenyl compounds useful for the treatment of liver diseases
JP2815402B2 (ja) * 1989-06-12 1998-10-27 タマ生化学株式会社 グリチルリチン製剤
WO1992001393A1 (fr) * 1990-07-18 1992-02-06 Nippon Hypox Laboratories Incorporated Composition pour aliment fonctionnel preparee a partir d'un extrait de reglisse
JP3090980B2 (ja) 1991-07-05 2000-09-25 勲 北川 肝細胞増殖促進剤および肝障害防止剤
JPH0614746A (ja) 1992-06-29 1994-01-25 Oomiya Yakugyo Kk 健康飲料
JPH06192107A (ja) * 1992-12-25 1994-07-12 Sanwa Kagaku Kenkyusho Co Ltd グリチルリチン経口剤
US6099844A (en) * 1994-08-22 2000-08-08 Triarco Industries, Inc. Increasing yield of extractable substances from botanicals with an enzyme composition
JPH09143085A (ja) 1995-11-17 1997-06-03 Eisai Co Ltd 甘草成分含有強肝剤
CN1448497A (zh) * 2002-03-28 2003-10-15 庄玉坤 减轻肝损伤或者不损伤肝脏的酒类饮料
US6855526B2 (en) * 2002-05-15 2005-02-15 The United States Of America As Represented By The Secretary Of Agriculture Method for making mannitol with Lactobacillus intermedius
FI20021819A0 (fi) 2002-10-14 2002-10-14 Pekka Untamo Heino Valmiste alkoholin metabolian tehostamiseksi
JP4601936B2 (ja) 2002-10-29 2010-12-22 株式会社ミノファーゲン製薬 Ｍｃｐ−１産生抑制のための薬学的組成物
WO2005006890A2 (en) * 2003-07-10 2005-01-27 Forest Carl A Foods, beverages, condiments, spices and salad dressings with specialized supplements
KR101153250B1 (ko) 2003-08-12 2012-06-05 니폰 조키 세야쿠 가부시키가이샤 글리시리진 고농도 제제
KR100543257B1 (ko) 2003-10-02 2006-01-20 재단법인서울대학교산학협력재단 감초 추출물 또는 리퀴리티게닌을 포함하는 중금속중독으로 인한 질환의 치료 및 예방용 조성물
CN100539877C (zh) * 2005-07-05 2009-09-16 黄恒燊 解酒保肝饮料及其制备方法
KR100697056B1 (ko) * 2006-01-09 2007-03-20 재단법인서울대학교산학협력재단 리퀴리티게닌을 유효성분으로 포함하는 간질환의 예방 및치료용 조성물
CN100455215C (zh) * 2006-06-05 2009-01-28 谢春生 一种具有解酒功能的梨汁饮料及其制备方法
US20100003364A1 (en) 2006-11-08 2010-01-07 Mohsen Daneshtalab Reduced-hangover alcoholic beverage comprising turmeric
KR20080002772U (ko) * 2007-01-17 2008-07-22 방기덕 저고온 액화 포도주
US20080226787A1 (en) 2007-03-14 2008-09-18 Concentrate Manufacturing Company Of Ireland Ammoniated Glycyrrhizin Modified Sweetened Beverage Products
CN101687909B (zh) * 2007-03-23 2013-12-18 日清药业股份有限公司 预防或治疗肝脏疾病的组合物
JP2008266203A (ja) 2007-04-19 2008-11-06 Bussan Food Science Kk 活性酸素種消去酵素群の活性を向上させる方法
US20090162483A1 (en) * 2007-12-20 2009-06-25 Wendy Lynn Constantine Sports beverage and method of making
CN101473985A (zh) * 2007-12-31 2009-07-08 天津中新药业研究中心 一种含有中药提取物和氨基酸成分饮料的制备方法
US20100086666A1 (en) 2008-10-03 2010-04-08 Andrew Adelman Alcoholic beverage
CN101744865B (zh) 2008-12-18 2012-07-25 山东福田药业有限公司 一种木糖醇护肝片的制备方法
US20090196951A1 (en) 2009-03-16 2009-08-06 Ross Brandborg Product and Method for Alcoholic Beverage Infused with Resveratrol
IT1399791B1 (it) 2009-04-20 2013-05-03 Drugs Minerals And Generics Italia S R L In Forma Abbreviata D M G Italia S R L Composizioni farmaceutiche per il trattamento della poliposi nasale
US8524785B2 (en) 2009-09-04 2013-09-03 International Flavors And Fragrances Inc. Methods for using rebaudioside C as a flavor enhancer
CN101946947A (zh) * 2010-09-01 2011-01-19 佛山市昌荣农业科技有限公司 一种灵芝葛根汁
CN102450714A (zh) * 2010-10-22 2012-05-16 赵强 一种解酒饮料及其制备方法
CN102450712A (zh) 2010-10-22 2012-05-16 赵强 一种玉米须营养液
CN102660445A (zh) * 2012-06-06 2012-09-12 重庆修贤商贸有限公司 功能性低损伤养生酒

Also Published As

Publication number Publication date
CA2909855A1 (en) 2014-11-06
JP2016516442A (ja) 2016-06-09
IN2013CH01894A (https=) 2015-10-02
MX2015014956A (es) 2016-08-08
JP6194412B2 (ja) 2017-09-06
WO2014177989A3 (en) 2015-03-05
EP2992078A2 (en) 2016-03-09
US20150141358A1 (en) 2015-05-21
AU2014261082A1 (en) 2015-12-17
WO2014177989A2 (en) 2014-11-06
ES2743075T3 (es) 2020-02-18
EA201592077A1 (ru) 2016-05-31
BR112015026884A2 (pt) 2017-07-25
CN105143428A (zh) 2015-12-09
US9149491B2 (en) 2015-10-06
EP2992078B1 (en) 2019-06-12
US10039776B2 (en) 2018-08-07
CN105143428B (zh) 2017-08-25
EA030485B1 (ru) 2018-08-31
US20170071963A1 (en) 2017-03-16
AU2014261082B2 (en) 2016-06-16

Similar Documents

Publication Publication Date Title
CA2909855C (en) Reduced toxicity in alcoholic beverages
Park et al. The antioxidant activities of Korean Red Ginseng (Panax ginseng) and ginsenosides: a systemic review through in vivo and clinical trials
Pingili et al. A comprehensive review on hepatoprotective and nephroprotective activities of chrysin against various drugs and toxic agents
Seiva et al. Quercetin ameliorates glucose and lipid metabolism and improves antioxidant status in postnatally monosodium glutamate-induced metabolic alterations
Tu et al. Natural compounds in the chemoprevention of alcoholic liver disease
Choi et al. Glycoprotein isolated from Acanthopanax senticosus protects against hepatotoxicity induced by acute and chronic alcohol treatment
CN107949394A (zh) 包含黑豆叶提取物及从其分离的黄酮醇苷作为活性成分的用于预防或治疗代谢综合征或用于抗氧化的组合物
Govindan et al. Antidiabetic activity of polysaccharide from Hypsizygus ulmarius in streptozotocin-nicotinamide induced diabetic rats
JP2018517782A (ja) 相乗的飲料組成物
Zhao et al. Attenuation of beryllium induced hepatorenal dysfunction and oxidative stress in rodents by combined effect of gallic acid and piperine
Yamaoka Activation of antioxidant system by low dose radiation and its applicable possibility for treatment of reactive oxygen species-related diseases
Gomez-Zorita et al. Isorhamnetin: Current knowledge and potential benefits for disease management
Kolure et al. Protective effect of enicostemma axillare-swertiamarin on oxidative stress against nicotine-induced liver damage in sd rats
Wang et al. Protective effects of corni fructus extract in mice with potassium oxonate–induced hyperuricemia
US11458155B1 (en) Active ingredient complexes, compositions and methods for hangover relief and to ameliorate alcohol-induced liver damage
US20190070245A1 (en) Nutriprotective diet
Wang et al. Effect of water caltrop (Trapa bispinosaRoxb.) pericarp extract on improving insulin resistance in STZ-induced diabetic mice
Zhang et al. Ergothioneine Attenuates CCl4‐Induced Acute Liver Injury by Inhibiting Oxidative Stress and Apoptosis via Regulating LKB1/Nrf2 Pathway
Suman et al. Evaluation of antidiabetic efficacy of Murraya koenigii on Streptozotocin induced diabetes in experimental rats
Hassanein et al. Methylseleninic acid and grape seed extract alleviate tamoxifen induce hepatotoxicity in rats
Wang et al. Molecular Mechanisms of Aflatoxin B1-Induced Renal Injury and the Detoxification Potential of Taraxasterol: A review
Obydah et al. Role of melatonin, glutamine and L-arginine in prevention of non-alcoholic fatty liver disease in rats
Shelbaya Effect of ginseng (panax ginseng) against testicular toxicity induced by sodium valproate in male rats
Ganiyu et al. Acetaminophen-induced liver injury: protective effect of Laportea aestuans aqueous leaf extract in experimental mice model
Areej Senjalawi., et al.“Egyptian Chicory (Cichoriumintybu) vsJordian One in Treatment of Liver of MSU-Induced HyperUricemia Experimental Rats

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20160502

H11 Ip right ceased following rejected request for revival

Free format text: ST27 STATUS EVENT CODE: T-6-6-H10-H11-H101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: TIME LIMIT FOR REVERSAL EXPIRED

Effective date: 20251029

H13 Ip right lapsed

Free format text: ST27 STATUS EVENT CODE: N-4-6-H10-H13-H100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE AND LATE FEE NOT PAID BY DEADLINE OF NOTICE

Effective date: 20251106

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: N-6-6-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20251110